CoChat

Estrogen Activation of the Nuclear Orphan Receptor CAR (Constitutive Active Receptor) in Induction of the Mouse Cyp2b10 Gene

Open access
Kawamoto, Takeshi, Kakizaki, Satoru, Yoshinari, Kouich, Negishi, Masahiko · 2000 · Molecular Endocrinology

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

The nuclear orphan receptor CAR (constitutively active receptor or constitutive androstane receptor) can be activated in response to xenochemical exposure, such as activation by phenobarbital of a response element called NR1 found in the CYP2B gene. Here various steroids were screened for potential endogenous chemicals that may activate CAR, using the NR1 enhancer and Cyp2b10 induction in transfected HepG2 cell and/or in mouse primary hepatocytes as the experimental criteria. 17beta-Estradiol and estrone activated NR1, whereas estriol, estetrol, estradiol sulfate, and the synthetic estrogen diethylstilbestrol did not. On the other hand, progesterone and androgens repressed NR1 activity in HepG2 cells, and the repressed NR1 activity was fully restored by estradiol. Moreover, estrogen treatment elicited nuclear accumulation of CAR in the mouse livers, as well as primary hepatocytes, and induced the endogenous Cyp2b10 gene. Ovariectomy did not affect either the basal or induced level of CAR in the nucleus of the female livers, while castration slightly increased the basal and greatly increased the induced levels in the liver nucleus of male mice. Thus, endogenous estrogen appears not to regulate CAR in female mice, whereas endogenous androgen may be the repressive factor in male mice. Estrogen at pharmacological levels is an effective activator of CAR in both female and male mice, suggesting a biological and/or toxicological role of this receptor in estrogen metabolism. In addition to mouse CAR, estrogens activated rat CAR, whereas human CAR did not respond well to the estrogens under the experimental conditions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/mend.14.11.0547

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Cited by

Items 101–185 of 185

Metadata

Authors
Kawamoto, T., Kakizaki, S., Yoshinari, K., & Negishi, M.
Affiliations
National Institutes of Health (US)
Corresponding author
Negishi, Masahiko
Venue
Molecular Endocrinology
Published
2000-11
Volume
14
Issue
11
Pages
1897-1905
ISSN
  • 0888-8809 (ISSN-L)
  • 1944-9917
OpenAlex
W2149182910
Cited by
168
References
17
Citations by year
2026: 4 · 2025: 4 · 2024: 4 · 2023: 6 · 2022: 4 · 2020: 2 · 2019: 5 · 2018: 4 · 2017: 6 · 2016: 6 · 2015: 3 · 2014: 4 · 2013: 11 · 2012: 14
FWCI
6.45
Type
journal article
Language
en
Open access
Locations
  • Molecular Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Keywords
constitutive androstane receptor, Cyp2b10, estradiol, estrone, sex differences, ovariectomy, castration, estrogen metabolism
MeSH terms
Cytochrome P450 Family 2, Constitutive Androstane Receptor, Androgens, Animals, Aryl Hydrocarbon Hydroxylases, Cytochrome P-450 Enzyme System, Enhancer Elements, Genetic, Estrogens, Female, Humans, Liver, Male, Mice, Inbred ICR, Ovariectomy, Progesterone, Species Specificity, Steroid Hydroxylases, Steroids, Transcription Factors, Transfection, Receptors, Cytoplasmic and Nuclear, Hepatocytes, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.